KPV

KPV is the C-terminal tripeptide of α-melanocyte-stimulating hormone (α-MSH), consisting of lysine, proline, and valine. Although it originates from a melanocortin peptide, research indicates that KPV does not simply reproduce the receptor-mediated signaling profile of full-length α-MSH. [1] 

Instead, experimental studies have identified mechanisms that are predominantly melanocortin-receptor-independent involving cellular uptake and intracellular regulation of signaling pathways.

PepT1-Mediated Cellular Uptake

One of the best-characterized mechanisms involves PepT1 (SLC15A1), a proton-coupled oligopeptide transporter capable of transporting KPV into cells. Studies using intestinal epithelial and immune-cell models found that PepT1-mediated uptake increased intracellular KPV and was associated with changes in NF-κB and MAPK signaling. [2] These findings distinguish KPV from peptides whose primary activity depends on binding to a cell-surface receptor.

NF-κB Signaling

Following cellular uptake, KPV has been investigated for its effects on the NF-κB signaling pathway, a major intracellular pathway involved in transcriptional responses to cellular stimuli. Experimental work has shown that KPV can reduce NF-κB activation and inhibit nuclear translocation of the p65/RelA subunit in specific cellular models. [3] One proposed mechanism involves KPV accumulating in the nucleus and interfering with the interaction between p65/RelA and importin-α3, thereby affecting the nuclear transport step required for NF-κB signaling.

MAPK and Related Signaling

Research has also associated KPV exposure with changes in mitogen-activated protein kinase (MAPK) signaling. In intestinal epithelial and immune-cell models, KPV was reported to reduce activation of NF-κB and MAPK pathways following experimental stimulation. [2] These findings provide a basis for studying KPV as a molecular probe of interconnected intracellular signaling pathways rather than assigning the peptide a single receptor-mediated mechanism.

Melanocortin Receptor Independence

KPV is derived from α-MSH, but its experimental activity should not automatically be attributed to the melanocortin receptors activated by the full-length peptide. Studies have reported KPV activity in models where melanocortin receptor involvement was not required, supporting an intracellular mechanism involving PepT1 and NF-κB regulation.

Other experimental systems have reported interactions with melanocortin-related signaling, so the precise mechanism can depend on the cell type and experimental conditions.

Overall, KPV provides a useful research model for investigating short peptide uptake, intracellular peptide signaling, NF-κB regulation, MAPK pathways, and the relationship between peptide sequence and cellular activity. The available evidence supports several mechanistic components, but KPV should not be described as having one universally established mechanism across all experimental systems.

KPV Research Applications

KPV is a small peptide fragment with a well-defined three-amino-acid sequence, making it useful for experimental studies of peptide transport, intracellular signaling, and cellular responses. Research applications include:

PepT1 Transport Research

KPV has been investigated as a substrate for peptide transporter 1 (PepT1/SLC15A1), a proton-coupled transporter capable of transporting di- and tripeptides into cells. Experimental studies have used KPV to investigate PepT1-mediated cellular uptake and the relationship between peptide transport and intracellular signaling in intestinal epithelial and immune-cell models. [2]

NF-κB Signaling Research

KPV has been used in cellular models to investigate NF-κB signaling, including activation of the transcription factor and nuclear localization of its p65/RelA subunit. Studies in epithelial-cell systems have examined KPV-associated changes in p65 nuclear transport and the interaction between p65/RelA and importin-α3. [3]

MAPK and Intracellular Signaling

Experimental studies have also investigated KPV in relation to MAPK signaling and other intracellular pathways. These models provide a basis for examining how a short peptide fragment can influence interconnected cellular signaling networks following peptide uptake. [2]

Epithelial and Cellular Biology

KPV has been investigated in several epithelial-cell and immune-cell models, including intestinal and airway epithelial systems. These studies provide experimental models for examining peptide uptake, intracellular localization, transcription-factor signaling, and cellular responses to defined experimental stimuli. [2][3]

Peptide Structure and Mechanism Research

Because KPV corresponds to the C-terminal tripeptide sequence of α-MSH, it also provides a useful model for studying how a short peptide fragment can exhibit molecular activity distinct from its longer parent peptide. Comparisons involving KPV, α-MSH-derived sequences, and modified analogs have been used to investigate sequence-dependent activity and the relative contribution of receptor-dependent and intracellular mechanisms.

Note that the specific mechanisms observed can vary according to cell type and experimental conditions, so findings from one model should not automatically be generalized to other systems.

KPV vs Melanotan I vs Melanotan II Comparison

KPV is the C-terminal tripeptide fragment of α-MSH, while Melanotan I and Melanotan II are longer synthetic α-MSH analogs developed through melanocortin structure-activity research. Comparing them highlights important differences in peptide length, structure, receptor pharmacology, and experimental use.

Note: All materials listed for laboratory research use only

The distinction between these compounds is particularly relevant when designing comparative experiments. KPV is best suited to research questions involving a short α-MSH-derived fragment, peptide transport, and intracellular signaling, whereas Melanotan I and Melanotan II are more directly associated with melanocortin receptor ligand pharmacology. Studies of Melanotan I and Melanotan II have demonstrated how sequence modification, truncation, and cyclization can substantially alter receptor binding and signaling properties.

For researchers investigating KPV specifically, the comparison with these longer melanocortin peptides can therefore help separate sequence-fragment effects from conventional melanocortin receptor pharmacology.

Storage & Handling

KPV is supplied as a lyophilized research peptide. As such, appropriate storage and handling can help maintain the material's chemical integrity and minimize exposure to moisture, light, and temperature fluctuations.

• Long-term storage: Store at −4°F or below (−20°C) according to laboratory SOPs and manufacturer guidance.

• Short-term storage: Refrigerated storage at 36–46°F (2–8°C) may be appropriate for short-term handling.

• Protect from moisture: Keep the vial tightly sealed and minimize exposure to ambient humidity.

• Protect from light: Store in a light-protected environment, particularly during extended storage.

• Minimize temperature cycling: Avoid unnecessary movement between different storage temperatures.

• Maintain vial integrity: Keep the original container sealed until the material is required for laboratory use.

• Follow laboratory procedures: Handling and storage should follow applicable institutional SOPs and laboratory quality-control procedures.

The appropriate storage period can depend on the peptide, packaging, and storage conditions. Researchers should refer to the applicable product documentation and batch-specific information when establishing storage procedures for a particular lot.

Certificate of Analysis & Quality Testing

Bluum Peptides usually commissions independent tests for each new batch of research peptides, including KPV, before it is made available for laboratory research. Testing documentation is provided in the form of a Certificate of Analysis which contains analytical results for purity, identity, and other applicable quality parameters; these results are tied to that specific production lot.

Researchers can use the documentation to verify:

• HPLC purity: reports the relative purity of the target peptide within the analyzed sample.

• Identity confirmation: mass-spectrometric analysis can be used to compare the observed molecular mass with the expected molecular weight for KPV.

• Batch or lot number: links the analytical results to the specific production batch.

• Date of analysis: establishes when the reported testing was performed.

• Endotoxin testing: provides the reported endotoxin result where applicable.

• Testing laboratory: identifies the independent laboratory responsible for the analytical testing.

HPLC measures the relative proportion of the target peak, while mass spectrometry provides molecular identity information. Reviewing both provides a more complete picture of a research peptide's analytical characterization.

KPV is provided strictly as a research material for qualified laboratory and scientific use. It is not intended for human or veterinary use, consumption, diagnostic purposes, or use in the treatment, prevention, or mitigation of any disease or condition. Researchers are responsible for handling and using the material in accordance with applicable laboratory procedures, institutional requirements, and relevant laws and regulations.

Frequently Asked Questions

What is KPV peptide?

KPV is a synthetic tripeptide consisting of the amino acids lysine, proline, and valine (Lys-Pro-Val). It corresponds to residues 11–13 at the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH) and is also referred to as α-MSH(11–13). Research has investigated KPV in experimental models involving peptide transport, intracellular signaling, NF-κB and MAPK pathways, and cellular biology.

What is KPV peptide used for in research?

KPV is used as a research material for investigating short-peptide transport, intracellular signaling, and cellular pathway regulation. Experimental studies have examined KPV in relation to PepT1-mediated uptake, NF-κB signaling, MAPK pathways, nuclear transport, and responses in epithelial and other cell models. Its small size also makes it useful for studying the molecular properties of short peptide fragments.

How is KPV related to alpha-MSH?

KPV is the C-terminal tripeptide fragment of α-MSH, corresponding to amino acid residues 11–13. Although KPV is derived from α-MSH, it should not be assumed to reproduce the complete biological activity or receptor-signaling profile of the full-length peptide. Experimental research has identified mechanisms involving cellular uptake and intracellular signaling that are distinct from conventional α-MSH receptor activity.

How does KPV interact with PepT1?

KPV can be transported into cells through peptide transporter 1 (PepT1/SLC15A1), a proton-coupled oligopeptide transporter. Experimental studies have used KPV to investigate PepT1-mediated uptake and the relationship between intracellular peptide transport and downstream signaling. Research in intestinal epithelial and immune-cell models has associated KPV uptake with changes in NF-κB and MAPK signaling.

How does KPV affect NF-κB and MAPK signaling in research models?

Experimental studies have reported changes in NF-κB and MAPK signaling following KPV exposure in specific cellular models. Research has examined effects on NF-κB activation, p65/RelA nuclear translocation, IκBα stabilization, and related signaling events. These findings are model- and condition-dependent and provide a basis for studying KPV as a molecular probe of intracellular signaling pathways.

Does KPV act through melanocortin receptors?

KPV should not be characterized simply as a conventional melanocortin receptor agonist. Although it is derived from α-MSH, experimental studies have reported KPV activity in models where melanocortin receptor activation was not required. Research has instead identified mechanisms involving PepT1-mediated uptake and intracellular regulation. Other experimental systems have reported melanocortin-related responses, indicating that the mechanism can depend on the model and experimental conditions.

How is KPV tested for purity and identity?

Bluum Peptides has each new batch of KPV independently tested by third-party laboratories. Analytical documentation can include HPLC purity analysis, identity confirmation, endotoxin testing, and other applicable quality parameters. The product is supplied with a batch-specific Certificate of Analysis (COA), and researchers should refer to the applicable COA for the exact analytical results of the lot provided.

Where can I buy KPV peptide for laboratory research?

KPV for sale is available from Bluum Peptides as a 10 mg lyophilized research peptide. The product is supplied in a sealed 3 mL vial with batch-specific analytical documentation. Typical purity exceeds 99%, and researchers can consult the applicable COA for the exact results associated with the current batch. KPV is sold strictly for laboratory research use only and is not intended for human or veterinary use.

Scientific References

1. Luger TA, Brzoska T. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii52-5.
https://pubmed.ncbi.nlm.nih.gov/17934097/

2. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008 Jan;134(1):166-78.
https://pubmed.ncbi.nlm.nih.gov/18061177/

3. Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol. 2012;4(2):59-73.
https://pubmed.ncbi.nlm.nih.gov/22837805/